ABSTRACT: Diabetes mellitus is a common
INTRODUCTION
Diabetes mellitus is a most common metabolic disorder of human beings. It is global in distribution affecting 2 to 6 percent population of the World. Gupta et al. (1975) have reported the incidence of diabetes mellitus more in Indian urban community (3.04)% than rural population (1.29%). Caraka and Susruta (400 B. C.) have discussed the honey urine (Madhumeha) in detail. However the name 'Diabetes' was given by two Roman physicians, Celsus and Aretaeus in 1 st A. D. and in 1921, Banting and Best solved the problem to a great extent by extracting the insulin from pancreas. But the long term complications are not preventable by the present mode of therapy. Insulin is available in various forms but prick pain, risk of hypoglycaemic encephalopathy, and possibility of development of insulin antibodies on long term use limit its utility.
Oral hypoglycaemic agents also poses some side effects.
In Ayurveda, various herbs like Haridra, Jamun, Karela etc. have been prescribed for the treatment of Madhumeha. Susruta has given the emphasis on the utility of Vaijayanti (Arani) in Iksumeha (Su. Ci. 11/9). There are found two varieties of Arani -big and small. Shankaran et al. (1963) have studied the effect of one variety of Arani Premna integrifolia in diabetes mellitus. Therefore another variety of Arani i.e. Clerodendron phlomidis ( Fig. 1 ) was selected for this study. This plant of about 9 meter heigh belongs to Verbenaceae family. Arani is one of the ingredient of Brhat Panca Mula. Arani is bitter and pungent in taste, katu in Vipaka and Usna in Virya. It normalizes the vitiated Kapha and Vata Dosa.
However, the foundation of therapeutics lies on the experimental analysis. Therefore, controlled experiments were carried out in this study. Effects of decoction and alcoholic extractives of Arani were observed in adrenaline induced hyperglycaemia. The results were compared with Tolbutamide. The effect of Arani was also seen on alloxan diabetic rats. Moreover a clinical trial was also conducted to evaluate the anti diabetic effect of Arani.
The results were encouraging.
The details of these experimental and clinical studies are being described here.
EXPERIMENTAL STUDY

Material and Methods:
Different solvent extractive of Arani were prepared and their effect on fasting blood sugar levels were studied in normal rats. Alcoholic extractive exhibited greatest hypoglycaemic effect.
Therefore the alcoholic extractive of Arani along with decoction of Arani (because of popular use of decoction of Ayurvedic herbal drugs) was subjected to observe anti -blood sugar effect.
In the first experiment the effect of Arani was studied in adrenaline induced hyperglycaemia.
24 albino rats were divided into four groups of six each. After an overnight fast, blood samples were taken. Then animals were fed with their respective drugs. The decoction of Arani was given to the first group in doses of 4 ml. (1.0 gm crud drug) per day to each rat. The rats of third group were treated with a known oral hypoglycaemic drug, tolbutamide, doses of 500 mg/kg body weight per day. The fourth group was taken as control. After half an hour of feeding, adrenaline hydrochloride was injected subcutaneously to each rat in doses of 0.5 mg. per kg. body weight. The blood samples were then collected at first hour, second hour and third hour for sugar estimation.
In the second experiment of comparative study of tolbutamide and Arani decoction was done in two steps in separate groups each of six healthy albino rats. In the first step, after a fast for 18 hours blood samples were taken and then tolbutamide (500 mg/kg) was given to first group and Arani decoction (4.0 ml = 1.0 gm. crude drug / rat) was fed to another group. Blood sugar values were then estimated after one hour, two hours and three hours. In the second step tolbutamide and Arani decoction were given to separate groups in above mentioned doses for one month. Blood samples were collected at the end of 10 days, 20 days and finally after 30 days.
The effect of decoction and alcoholic extractive of Arani on blood sugar of alloxan diabetic rats were studied in the third experiment. 18 healthy rats were taken for this study. Alloxan monohydrate was given to them in doses of 150 mg/kg intraperitoneally. Glucose solution (10 -15%) was given orally till permanent hypoerglycaemia was established. After 3 -4 days animals required insulin (2 -4 units) daily in addition of feeding. Only those animals which showed hyperglycaemia even after a period of 10 days of alloxan administration, were selected for this study. Insulin and feeding were discontinued for two days and fasting samples were taken. Then animals were divided into three groups. One group was orally fed with 4 ml. decoction (1.0 gm crude drug); other with 0.5 ml of alcoholic extractive of Arani (2.0 gm crud drug) and the last with 4 ml. of water daily to each rat. Blood samples were then taken after two hours and four hours.
RESULTS AND OBSERVATIONS:
The different blood sugar values obtained in the first experiment are given in table -1. The highest rise in blood sugar level was obtained at the end of second hour of adrenaline injection. Thereafter the blood sugar contents began to fall. The observed mean percent rise per hour by adrenaline in the Arani -alcoholic extractive treated group was 5.28. It was well comparable to that observed in tolbutamide group (2.23). However, in Arani -decoction treated group the mean percent rise was more i.e. 10.9.
The second experiment was conducted in two steps. The The values of blood sugar as obtained in third experiment in alloxan diabetic rats are given in table 4 control groups which was treated with plain water showed 13% fall per hour. In the group of Arani decoction treated rats, reduction % per hour was 27.78, and for alcoholic extractive treated group were 27.83.
DISCUSSION
The adrenaline induced hyperglycaemia is the result of mobilization of liver glycogen, reduction in muscle glycogen, reduction in muscle glycogen with the conversion of resultant lactic acid to blood sugar in the liver, and diminution in peripheral glucose utilization (Sutherland, 1952) . It is evident from table -1 that both prepartions of Arani -decoction and alcoholic extractive inhibit adrenaline induced hyperglycaemia. However, alcoholic extractive revealed greater inhibitory effect at the end of second hour as compared with that of decoction.
Both of these preparations exhibited significant inhibition in rise of blood sugar after 2 nd and 3 rd hour of adrenaline injection. A greater significant 'p' value -<0.001 (Table -5 ), was observed in 2 nd and 3 rd hour in the alcoholic extractive treated group. It shows more inhibitory action of alcohol extractive on adrenaline response of animals than that of decoction of Arani. The results are well depicted in Fig.2 .
Janbon and his associated (1942), firstly observed the hypoglycaemic action of sulfonamides. However in 1955, Frank and Fuschs confirmed the blood sugar lowering action of carbutamide, a sulfonamide using it for an infectious disease.
But the incidence of side effects was considered to be high for general use. Sooner, the first sulfonyl urea compound, tolbutamide was introduced for general use in diabetes in U S A in 1957. Tolbutamide was well described by Kautz (1957) , the secretory of Council on Drugs (America). It stimulates the release of insulin by beta cells and also inhibts neoglucogenesis and glycogenolysis. Kulkarni and Gaitonde (1962) have reported 24% fall in fasting blood sugar of rats after 4 hours of Tolbutamide (500 mg/kg) administrations. In the present series it was 29% after 3 rd hour. It is well comparable (Table -2 ). The fall with both the Arani decoction and tolbutamide was found significant (p<0.05). It appears, therefore, that the decoction of Arani compared favourably with Tolbutamide in its immediate effect. Moreover, decoction of Arani also produced a fall of 20.7% on long term use for a month (Table -3 ) which is also comparable to fall produced by Jasad Bhasma i.e. 22% observed by Kulakarni and Gaitoned (1962) . This fall percentage of Arani decoction after a month use was found highly significant (<0.01). However, it was somewhat less than that of Tolbutamide (35.4%) which was also more significant (p<0.001).
There are certain chemical agents like alloxan, streptozotocni, Vacor (rat poison) which produce hypoinsulinomic diabetes mellitus. However, alloxan is still the popularly used compound to produce experimental diabetes in animals. Dunn et al. (1943) Moreover, in adrenaline induced hyperglucaemic rats the alcoholic extractive of Arani showed comparable inhibitory effect to that of tolbutamide at the peak time of hyperglycaemia i.e. at the end of second hour (Table -1 ). There was not observed much difference in the mean percent rise per hour of talbutamide treated group and the group treated with alcoholic extractive (Table -1 ). On statistical analysis too, both the Arani decoction and tolbutamide exhibited equally highly significant (p<0.001) inhibitory effect ( Table -5) . Therefore Arani appears well comparable to tolbutamide in its hypoglycaemic effect both in normal rats and in adrenaline induced hyperglycaemic rats.
CLINICAL STUDY MATERIAL AND METHODS:
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The clinical study was conducted on 23 patients with proved diabetes mellitus in S. S. Hospital, B. H. U. These patients were divided into four groups. The first group consisting of 13 patients was treated with Arani decoction (1:4) in the doses of 15 to 30 gm. of crude drug per day in divided doses. Tolbutamide (500 mg/day) was given to the 3 diabetics of second group. The third group (3 patients) was treated with 30 units of insulin daily whereas fourth group of 4 cases was kept was control (diet group) without any treatment. The mean duration of treatment was 5.2 weeks in Arani group, 2 weeks in tolbutamide group 2.3 weeks in insulin group. All the patients were kept on same hospital diet consisting of 2425 calory.
RESULTS AND OBSERVATIONS:
The mean duration of illness was 6 years in this series. Polydypsia and polyuria were present in all the patients. Weakness, constipation and hyperplasia were the next complaints.
A marked symptomatic improvement was observed in Arani treated diabetic patients. Urine became free of sugar in 46% cases. A fall in percentage of urine sugar was also produced in the rest of the cases. Likewise, a marked reduction in blood sugar values of these patients was also observed in this study. Mean values of blood sugar lowered down to 149 mg% from 202 mg%, and that of urine sugar to 0.8 mg% from 2.2 mg%. The reduction in mean values of blood sugar was to 137 mg% from 176 mg% in Tolbutamide group and to 191 mg% from 276 mg% in insulin group. The mean values of urine sugar came down to 1.5 gm% from 2.7 gm% in Tolbutamide group and to 1.3 gm% from 3.5 gm% in insulin group. However, in the control group the blood sugar mean values raised to 196 mg% from 185 mg% and urine sugar increased to 2.5 gm% from 2.1 gm%.
Moreover, glucose tolerance was also increased in Arani treated diabetic patients.
DISCUSSION
The observations of this clinical study exhibited a fall in blood sugar and urine sugar along with symptomatic improvement. The mean% weekly fall or rise was calculated in each group. The values are shown in fig. 3 . The mean% weekly fall in Arani group was 7.1 in blood sugar and 18.2 in urine sugar. These values in Tolbutamide group well 11.0 and 22.2 in Tolbutamide group which are slightly more than Arani group. However, the effect was less than insulin in both these groups but the fall was gradual. In control group a rise in blood sugar and urine sugar was observed. Clinically too, the condition of these patients deteriorated. The results are shown in fig.4 . On the total assessment based on symptomatic improvement and lowering the blood sugar and urine sugar values the 46% of diabetic patients responded well to Arani treatment ( Table -6 ). Neither did any patient complain of any side effect nor any change in routine blood values was observed during the course of Arani treatment.
Case Report
For a brief introduction, a case report is being described here R S U, 70 years old male, resident of Bihar was admitted with the complaints of polyuria, polydypsia, constipation, loss of vision, tingling and numbness in extremities for the duration of 10 years and complicated with pulmonary tuberculosis. Fasting blood sugar was 316 mg% and urine contained 4.0 gm% sugar, 30 gm% of crude drug. Arani was given to him daily in decoction from in four divided doses. Anti -tubercular treatment was, also given simultaneously. Three weeks of Arani treatment brought down the fasting blood sugar to 188 mg% and urine sugar 1.5 gm% (Fig. 5) . Then the dose was reduced to 22.5 gm. crude drug daily. During the follow up period, his blood sugar remained between 130 to 140 mg under the Arani treatment. Sugar became absent from the urine Polyuria and polydyspia were improved. This diabetic patient responded well to Arani treatment without any adverse effect.
Conclusion:
The problem of diabetes mellitus is as old as humanity. New discoveries pave the way for the newer adventures in the field of research. Insulin turned the course of the history of diabetes. The oral hypoglycaemic drugs helped the patient to forego the needle and syringe.
While insulin is only replacement therapy, the action of new oral hypoclycaemic compounds are still to be understood beyond doubts. Therefore a search to find out better oral antidiabetic drug is continued. In the present series the prescription of Susrutavaijayanti (Clerodendron phlomides) for the treatment of Iksumeha has been put on trial in experimental and clinical study. Arani exhibited significant inhibitory effect on adrenaline induced hyperglycaemia. In a comparative study, Arani produced well comparable fall in blood sugar values of albino rats to that of a known oral hypoglycaemic drug tolbutamide both on immediate effect as well on long term use. Arani also brought down the blood sugar levels effectively in alloxan diabetic rats. Moreover, in clinical study Aranidecoction exhibited good response in patients with diabetes mellitus. The fall in blood sugar was gradual. It produced no side effects. Comparatively / Arani showed somewhat similar response as that of tolbutamide. Therefore, the drug Arani (Clerodendron phlomides) appears to be a good oral hypoglycaemic drug. Vaidya et al (1962) have reported the efficacy of Bilva (Aegle marmalos) in diabetes mellitus. Consequently it is requested to evaluate the antidiabetic potentially of the remaining three constituents of Brahat-pancha Moola viz. Syonaka (Oroxylum indicum), patala (Stereospermum suaveolens) and Gambhari (Gmelina arborea). Thereby the Ayurveda can serve the suffering humanity.
